Top compounds associated with response to IGFALS


Feature Type Standardized
Nominal ANOVA
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.035 0.4
mRNA procarbazine CTRPv2 pan-cancer AAC 0.034 0.4
mRNA CAY10618 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA narciclasine CTRPv2 pan-cancer AAC 0.028 0.4
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.026 0.4
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.031 0.4
mRNA Axitinib CTRPv2 pan-cancer AAC -0.028 0.4
mRNA Rapamycin CTRPv2 pan-cancer AAC 0.028 0.4
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.03 0.4
Download CSV